No Data
No Data
No Data
No Data
No Data
Oncocyte Price Target Maintained With a $4.00/Share by Stephens & Co.
Oncocyte Price Target Maintained With a $4.00/Share by Stephens & Co.
Dow JonesApr 17 10:26 ET
Express News | Stephens & Co. Reiterates Equal-Weight on OncoCyte, Maintains $4 Price Target
Moomoo 24/7Apr 17 10:16 ET
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
BenzingaApr 15 14:11 ET
Oncocyte Price Target Maintained With a $5.00/Share by Benchmark
Oncocyte Price Target Maintained With a $5.00/Share by Benchmark
Dow JonesApr 15 11:19 ET
Express News | Benchmark Reiterates Speculative Buy on OncoCyte, Maintains $5 Price Target
Moomoo 24/7Apr 15 11:09 ET
OncoCyte Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/15/2024 96.08% Benchmark → $5 Reiterates Speculative Buy → Speculative Buy 11/13/2023 17.65% Piper Sand
BenzingaApr 15 11:06 ET
LDG_Jeff : I have no idea what caused this i am still trying to figure out
DeKingVibezOP LDG_Jeff: I’m still shocked. Lol or maybe because my money is here lol
LDG_Jeff DeKingVibezOP: Same
Daight :
short seller or market manipulator doing this.
that person has been trying to lower this from 4.7.
No Data
No Data